JP Morgan Chase
IPSC icon

JP Morgan Chase’s Century Therapeutics IPSC Stock Holding History

JP Morgan Chase’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$233 Sell
115
-2,962
-96% -$6.23K ﹤0.01% 7241
2025
Q4 		$3.06K Buy
3,077
+1,484
+93% +$905 ﹤0.01% 6881
2025
Q3 		$793 Sell
1,593
-1,044
-40% -$563 ﹤0.01% 7007
2025
Q2 		$1.47K Sell
2,637
-66,853
-96% -$35.9K ﹤0.01% 6575
2025
Q1 		$33.1K Sell
69,490
-93,699
-57% -$70.4K ﹤0.01% 6007
2024
Q4 		$165K Buy
163,189
+91,468
+128% +$125K ﹤0.01% 5563
2024
Q3 		$123K Buy
71,721
+51,664
+258% +$101K ﹤0.01% 5615
2024
Q2 		$51.1K Sell
20,057
-5,623
-22% -$17.8K ﹤0.01% 5852
2024
Q1 		$107K Buy
25,680
+10,498
+69% +$44.4K ﹤0.01% 5641
2023
Q4 		$50.4K Sell
15,182
-11,341
-43% -$20.7K ﹤0.01% 5998
2023
Q3 		$53K Buy
26,523
+5,807
+28% +$15.4K ﹤0.01% 5784
2023
Q2 		$65.5K Sell
20,716
-45,036
-68% -$145K ﹤0.01% 5644
2023
Q1 		$228K Buy
65,752
+291
+0.4% +$1.28K ﹤0.01% 4988
2022
Q4 		$335K Buy
65,461
+2,360
+4% +$22.3K ﹤0.01% 4760
2022
Q3 		$624K Sell
63,101
-2,255
-3% -$23.7K ﹤0.01% 4317
2022
Q2 		$548K Buy
65,356
+6,237
+11% +$61.2K ﹤0.01% 4495
2022
Q1 		$744K Sell
59,119
-81,834
-58% -$1.08M ﹤0.01% 4459
2021
Q4 		$2.23M Buy
140,953
+77,529
+122% +$1.46M ﹤0.01% 3775
2021
Q3 		$1.6M Buy
+63,424
New +$1.72M ﹤0.01% 3954

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

JP Morgan Chase's IPSC Position: Q1 2026 in Review

JP Morgan Chase reduced its Century Therapeutics (IPSC) stake by 96% in Q1 2026, selling an estimated $6.23K and leaving 115 shares worth $233. The position accounts for ﹤0.01% of the portfolio, ranked #7241.

JP Morgan Chase first reported a position in IPSC in Q3 2021 and has held it in 19 quarters since. The position peaked at $2.23M in Q4 2021. 72 funds tracked by Wall St. Rank hold IPSC as of Q1 2026.

  • JP Morgan Chase held 115 shares of Century Therapeutics worth $233 as of Q1 2026.
  • JP Morgan Chase sold 2,962 Century Therapeutics shares in Q1 2026, an estimated $6.23K.
  • Century Therapeutics made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #7241 holding.
  • JP Morgan Chase first reported a position in Century Therapeutics in Q3 2021 and has held it in 19 quarters since.
  • JP Morgan Chase's Century Therapeutics position peaked at $2.23M in Q4 2021.
  • 72 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.